Alerts will be sent to your verified email
Verify EmailBERLDRG
Beryl Drugs
|
Hind Bio Science
|
Cian Healthcare
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
2.54 % | -26.49 % | -2.49 % |
5yr average Equity Multiplier
|
2.23 | 3.5 | 2.79 |
5yr Average Asset Turnover Ratio
|
1.08 | 0.28 | 0.42 |
5yr Avg Net Profit Margin
|
0.66 % | -41.21 % | -2.06 % |
Price to Book
|
1.05 | 11.05 | 0.0 |
P/E
|
17.08 | 97.43 | 40.5 |
5yr Avg Cash Conversion Cycle
|
-619.24 Days | 136.38 Days | -692.15 Days |
Inventory Days
|
36.1 Days | 8.52 Days | 163.23 Days |
Days Receivable
|
98.89 Days | 155.27 Days | 131.14 Days |
Days Payable
|
969.29 Days | 118.59 Days | 473.59 Days |
5yr Average Interest Coverage Ratio
|
1.68 | -43.62 | 0.8 |
5yr Avg ROCE
|
5.73 % | -14.23 % | 5.59 % |
5yr Avg Operating Profit Margin
|
7.19 % | -39.73 % | 14.07 % |
5 yr average Debt to Equity
|
0.64 | 2.36 | 1.12 |
5yr CAGR Net Profit
|
72.78 % | -5.59 % | n/a |
5yr Average Return on Assets
|
1.31 % | -8.5 % | -0.86 % |
Shareholdings
|
|||
Promoter Holding
|
26.38 % | 12.19 % | 27.1 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 34.48 % |
Change in Promoter Holding (3 Yrs)
|
1.46 % | 0.0 | -43.79 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |